bioRxiv · 10.1101/352401
Enhanced β-secretase processing of amyloid precursor protein in the skeletal muscle of ALS animal models
Abstract
Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative disorder primarily characterized by motor neuron degeneration and muscle paralysis. Several studies indicate that pathological changes in the skeletal muscle contribute to disease progression. We report a significant increase of {beta}-secretase processing of amyloid precursor protein (APP) in the skeletal muscle but not the spinal cord or cerebral cortex of hSOD1 (G93A) transgenic ALS mouse models. Enhanced {beta}-secretase processing of APP was manifested by up-regulated expression of {beta}CTF, the 22-kd CTF of APP, and {beta}-secretase processing enzyme, BACE1. Morphological analysis demonstrated that enhanced {beta}-secretase processing of APP mainly occurred in the atrophic myofibers of ALS mice. We also observed a similar change in APP processing in an hSOD1 (G93A) transgenic ALS pig model, suggesting that enhanced {beta}-secretase processing of APP in skeletal muscle may be a common pathological feature of ALS. These findings reveal a selective change in APP processing in skeletal muscle of ALS animal models, and highlight the involvement of aberrant APP processing in ALS pathogenesis.
Explore related subjects
Keep this discovery
Yang, H.. 2018-06-24. Enhanced β-secretase processing of amyloid precursor protein in the skeletal muscle of ALS animal models. https://doi.org/10.1101/352401
Cite the original work for its findings. Save a collection to share your selection of sources.